THC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Tenet Healthcare Corp (THC) is a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The company's strong financial performance, bullish technical indicators, positive analyst sentiment, and hedge fund buying activity outweigh the minor insider selling and overbought RSI levels. The stock is well-positioned for growth, supported by robust Q4 results and upward revisions in price targets by multiple analysts.
The stock shows a bullish trend with MACD positively expanding (4.31), RSI at 85.368 indicating overbought conditions, and bullish moving averages (SMA_5 > SMA_20 > SMA_200). Key resistance levels are R1: 226.337 and R2: 237.965, with the current price at 228.63 above R1.
Hedge funds are significantly increasing their positions (+337.36% last quarter). Q4 2025 financials exceeded expectations with revenue up 8.97% YoY and EPS up 27.88% YoY. Analysts have raised price targets significantly, with the highest at $288, citing strong fundamentals and undervaluation.
Insider selling has increased by 1492.05% over the last month. RSI indicates overbought conditions, suggesting a potential short-term pullback.
In Q4 2025, revenue increased to $5.527 billion (+8.97% YoY), net income rose to $371 million (+16.67% YoY), and EPS grew to 4.22 (+27.88% YoY). Gross margin slightly declined to 77.55% (-0.40% YoY). The company also provided a strong 2026 revenue forecast above consensus estimates.
Analysts are overwhelmingly positive on THC, with multiple firms raising price targets recently. The highest target is $288 (UBS), and the lowest is $242 (TD Cowen). Analysts cite strong Q4 results, better-than-expected 2026 guidance, and undervaluation as reasons for their bullish outlook.
